Everolimus-based combination therapies for HR+, HER2-metastatic breast cancer

O'Shaughnessy, J; Beck, JT; Royce, M

O'Shaughnessy, J (reprint author), Baylor Univ, Med Ctr, Texas Oncol, US Oncol, 3410 Worth 54,Suite 400, Dallas, TX 75246 USA.

CANCER TREATMENT REVIEWS, 2018; 69 (): 204